Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction

Journal of Hepatology

Volumn 49, Issue 1, 2008, Pages 34-42

  Assy, Nimer ^a,c   Pruzansky, Yosef ^d   Gaitini, Diana ^b,c   Shen Orr, Zila ^b   Hochberg, Ze'ev ^b,c   Baruch, Yaacov ^c,d  

^a Rebecca Sieff Government Hospital   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c MEYER CHILDREN S HOSPITAL   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Ascites; Cirrhosis; CP score; Growth hormone (GH); Insulin like growth factor 1 (IGF 1); Liver function test; liver transplant; Malnutrition; MELD; Portal hypertension; Varices

Indexed keywords

ALBUMIN; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACCURACY; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; CHRONIC PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HORMONAL REGULATION; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIVARIATE ANALYSIS; NUTRITION; PORTAL CONGESTIVE INDEX; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCORING SYSTEM;

ADULT; AGED; ASCITES; DISEASE PROGRESSION; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERTENSION, PORTAL; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MALNUTRITION; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 44649157711     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.02.013     Document Type: Article

References (50)

1. Oellerich M., Burdelski M., Lautz H.U., Rodeck B., Duewel J., Schulz M., et al. Assessment of pre-transplant prognosis in patients with cirrhosis. Transplantation 51 (1991) 801-806
2. Testa R., Valente U., Risso D., Caglieris S., Giannini E., Fasoli A., et al. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?. Eur J Gastroenterol Hepatol 11 (1999) 559-563
3. Shrescha R., Mckinley C., Showalter R., Wilner K., Marsano L., Vivian B., et al. Quantitative liver function tests define the functional severity of liver disease in early-stage cirrhosis. Liver Transpl Surg 3 (1997) 166-173
4. Lucey M.R., Brown K.A., Everson G.T., Fung J.J., Gish R., Keefe E.B., et al. Minimal criteria for placement of adults on liver transplant waiting list. Transplantation 66 (1998) 956-962
5. Oellerich M., Burdwlski M., Lautz H.U., Binder L., and Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 14 (1991) 1029-1034
6. Arrigoni A., Gindro T., Aimo G., Capello N., Meloni A., Benedetti P., et al. Monoethylglycinexlydide test: a prognostic indicator of survival in cirrhosis. Hepatology 20 (1994) 383-387
7. Alder M., Versed D., Bouhadid H., Bourgeois N., Gulbis B., le Moine O., et al. Prognostic evaluation of patients with parenchymal cirrhosis. J Hepatol 26 (1997) 642-649
8. Jalan R., and Hayes P.C. Review article: quantitative tests of liver function. Aliment Pharmacol Ther 9 (1995) 263-270
9. Assy N., Hochberg Z., Enat R., and Baruch Y. Prognostic value of generation of growth hormone stimulated insulin like growth factor-1 (IGF-1) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci 43 (1998) 1317-1321
10. Assy N., Hochberg Z., Amit T., Shen-Orr Z., Enat R., and Baruch Y. Growth hormone stimulated insulin-like growth factor (IGF-1) and IGF-binding protein-3 in liver cirrhosis. J Hepatol 27 (1997) 796-802
11. Moller S., Becker U., Juul A., Skakkebaek N.E., and Christensen E. Prognostic value of insulin like growth factor 1 and its binding protein in patients with alcohol-induced liver disease. Hepatology 23 (1996) 1073-1078
12. Caregaro L., Alberino F., Amodio P., Merkel C., Angeli P., Plebani M., et al. Nutritional and prognostic significance of insulin like growth factor-1 in patients with liver cirrhosis. Nutrition 13 (1997) 185-190
13. Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J., and Ter Borg B.C. A model to predict poor survival in patients undergoing transjugular intrahepatic Porto systemic shunts. Hepatology 31 (2000) 864-871
14. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
15. Forman L.M., and Lucy M.R. Predicting the prognosis of chronic liver disease: an evaluation from child to MELD. Hepatology 33 (2001) 473-475
16. McCaughan G.W., and Strasser S.I. To MELD or not to MELD?. Hepatology 34 (2001) 215-216
17. Wiesner R.H., McDiarmid S.V., Kamath P.S., Edwards E.B., Malinchoc M., Kremers W.K., et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 7 (2001) 567-580
18. Juul A., and Moller S. IGF-1 in chronic liver disease: a marker of hepatocellular dysfuction, malnutrition, and survival?. Nutrition 13 (1997) 231-232
19. Blomsa M., De Knegt R.J., Dullaart R.P.F., and Jansen P.L.M. Insulin-like growth factor-1 in liver cirrhosis. J Hepatol 27 (1997) 1133-1138
20. Holt R.I.G., Jones J.S., Baker A.J., Buchanan C.R., and Miell J.P. The effect of short status, portal hypertension and cholestasis on growth hormone resistance in children with liver disease. J Clin Endocrinol Metab 84 (1999) 3277-3282
21. Pugh R.N.H., Murray Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 60 (1973) 646-664
22. Iwao T., Toyonaga A., Oho K., Tayama C., Masumoto H., Saki T., et al. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol 92 (1997) 1012-1017
23. Moriyasu F., Nishida O., Ban N., Nakamura T., Sakai M., Miyake T., et al. Congestion index of the portal vein. AJR Am J Roentgenol 146 (1986) 735-739
24. Schepis F., Camma C., Niceforo D., Magnano A., Pallio S., Cinquegrani M., et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?. Hepatology 33 (2001) 333-338
25. Bistrian B.R., Blackburn G.L., Sherman M., and Scrimshaw N.S. Therapeutic index of nutritional depletion in hospitalized patients. Surg Gynecol Obstet 141 (1975) 512-516
26. Morgan M.Y., Madden A.M., Soulsby C.T., and Morris R.W. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 44 (2006) 823-835
27. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., and Blei A.T. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
28. Bang P., Eriksson U., Sara V., Wivall I.L., and Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-1 and IGF-II radioimmunoassay assays: improvement of determination in acid ethanol extracts by the use of truncated IGF-I as radio legend. Acta Endocrinol 124 (1991) 620-629
29. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Gorgensen K., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults; relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78 (1994) 744-752
30. Moller S., Gronbaek M., Main K., Becker U., and Skakkebaek N.E. Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosis. J Hepatol 17 (1993) 315-320
31. Caufriez A., Reding P., Urbain D., Golstein J., and Copinschi G. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest 14 (1991) 317-321
32. Sheppard M.S., Minuk G.Y., Bhaumick B., and Bala R.M. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II. Clin Invest Med 10 (1987) 49-53
33. Caregaro L., Alberino F., Amodio P., Merkel C., Bolognesi M., Angeli P., et al. Malnutrition in alcoholic and virus related cirrhosis. Am J Clin Nutr 63 (1996) 602-609
34. Caregaro L., Alberino F., Angeli P., and Gatta A. Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: a marker of hepatocellular dysfunction?. J Hepatol 29 (1998) 342
35. Weber M.M., Auernhammer C.J., Lee P.D., Engelhardt D., and Zachoval R. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res 57 (2002) 105-112
36. Plevak D.J., DiCecco S.R., Wiesner R.H., Porayko M.K., Wahlstrom H.E., Janzow D.J., et al. Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc 69 (1994) 225-230
37. Moller S., Becker U., Gronbaek M., Juul A., Winkler K., and Skakkebaek N.E. Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis. J Hepatol 21 (1994) 710-717
38. Chapman I.M., Bach M.A., Van Cauter E., Farmer M., Krupa D., Taylor A.M., et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue in healthy elderly subjects. J Clin Endocrinol Metab 81 (1996) 4249-4257
39. Baruch Y., Amit T., Hertz P., Enat R., Youdim M.B., and Hochberg Z. Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 73 (1991) 777-780
40. Chang T.C., Lin J.J., Yu S.C., and Chang T.J. Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology 11 (1990) 123-126
41. Hochberg Z., Phillip M., Youdim M.B., and Amit T. Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatility. Metabolism 42 (1993) 1617-1623
42. Baruch Y., Assy N., Amit T., Krivoy N., Strickovsky D., Orr Z.S., et al. Spontaneous pulsatility and pharmacokinetics of growth hormone in liver cirrhotic patients. J Hepatol 29 (1998) 559-564
43. Scharf J.G., Schmitz F., Frystyk J., Skjaerbaek C., Moesus H., Blum W.F., et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 25 (1996) 689-699
44. Le Roith D. Seminars in medicine of the beth israel deaconess medical center. Insulin-like growth factors. New Engl J Med 336 (1997) 633-640
45. Moller S., Juul A., Becker U., Flyvbjerg A., Skakkebaek N.E., and Henriksen J.H. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab 80 (1995) 1148-1157
46. Phillips L.S., Pao C.I., and Villafuerte B.C. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acid Res Mol Biol 60 (1998) 195-265
47. Cuneo R.C., Hickman P.E., Wallace J.D., Teh B.T., Ward G., Veldhuis J.D., et al. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocrinol (Oxf) 43 (1995) 265-275
48. Blum W.F. Insulin-like growth factors and IGF-binding proteins: their use for diagnosis of growth hormone deficiency. In: Juul A., and Jorgensen J.O.L. (Eds). Growth hormone in adults. Physiological and clinical aspects (1996), Cambridge University Press, Cambridge, MA 48
49. Vizzutti F., Arena U., Romanelli R.G., Rega L., Foschi M., Colagrande S., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45 (2007) 1290-1297
50. Lorenzo-Zúñiga V., Bartoli{dotless}́ R., Masnou H., Montoliu S., Morillas R.M., and Planas R. Serum concentrations of insulin-like growth factor-I (IGF-I) as a marker of liver fibrosis in patients with chronic hepatitis C. Dig Dis Sci 52 (2007) 3245-3250